Dr. Lazaridis suggests Mayo Clinic is advancing the thought of bringing genetic screening to routine affected individual treatment to help determine people at high risk for most cancers as well as other diseases, enabling before screening and mitigating the potential risk of most cancers, the need to use expensive and limited therapies for Sophisti